Canadian guidelines recommend that women with a pre-pregnancy body mass index (BMI) at or above 40 kg/m2 deliver by their due date. When delivery is planned prior to spontaneous labour, there are two options: planned induction of labour or pre-labour Caesarean (C-section). However, it is not yet clear whether induction of labour or planned pre-labour C-section is the best option for this population. The MODE Trial aims to assess the feasibility of conducting a larger-scale trial of planned mode of delivery in first time mothers who have a BMI \>=40kg/m2, and obtain preliminary data on health outcomes for moms and babies following delivery by either planned C-section or induction of labour.
Women with obesity have a decreased likelihood of achieving vaginal delivery. According to the Centre for Maternal and Child Enquiries, the chance of spontaneous vaginal delivery in women with a BMI ≥35kg/m2 is 55%, while the chance is 36.7% in women with a BMI ≥40.0kg/m2. This number includes women who go into labour spontaneously, in which, the odds of a vaginal delivery are highest. The rate of failure to induce labour approaches 80% with increased complications and morbidity including abnormal fetal heart rate monitoring, labour dystocia, emergency C-section, and fetal macrosomia. It has been proposed that some women may benefit from a planned Caesarean section delivery. However, Caesarean sections are also not straightforward in women with obesity, and come with significant risks of short- and long-term morbidity for mother and baby, including prolonged operative times, higher volumes of blood loss and infection rates and higher rates of NICU admission. Given that there are many considerations when deciding how to best deliver a woman with obesity, it is not surprising that there is a high degree of clinical equipoise. In reality, the decision is made jointly between the patient and her care provider, often guided by overall instinct and local resource availability. Studies to date have been retrospective in nature. There is a significant need for prospective study of the outcomes and experiences of planned induction of labour and planned Caesarean section in women with obesity to allow evidence-based counselling and decision-making.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
100
Planned pre-labour Caesarean section at 38-40 weeks. For patients planning Caesarean Section, surgical planning, precise timing and method of Caesarean section is at the discretion of the most responsible care provider, as per local procedures.
Planned induction of labour at 38-40 weeks. For patients planning induction of labour, precise timing and method of induction of labour is at the discretion of the most responsible care provider, as per local procedures.
The Ottawa Hospital
Ottawa, Ontario, Canada
Feasibility of conducting a larger-scale trial (eligibility criteria)
Appropriateness of eligibility criteria, measured by the reasons for exclusion of screened patients
Time frame: 18 months
Feasibility of conducting a larger-scale trial (recruitment rate)
Eligibility and recruitment rate, measured by the proportion of patients who are eligible and recruited into the trial
Time frame: 18 months
Feasibility of conducting a larger-scale trial (randomization)
Appropriateness of randomization, measured by the proportion of trial participants who consent to randomization
Time frame: 18 months
Maternal morbidity and mortality
Rates of: maternal death, admission to ICU, intrapartum Caesarean section, postpartum hemorrhage, postpartum wound infection, endometritis, venous thromboembolism (VTE), hypertensive disorders of pregnancy (gestational hypertension or preeclampsia), indication for Caesarean delivery, operative vaginal delivery, indication for operative vaginal delivery, uterine incision extensions during Caesarean section, chorioamnionitis, third or fourth degree perineal lacerations, induction agents, pain medication use during induction, labour, Caesarean section and postpartum.
Time frame: Pregnancy to 6 week postpartum
Fetal and neonatal morbidity and mortality
Rates of: stillbirth, neonatal death, gestational age at birth, birthweight, need for respiratory support within 72 hours of birth, duration of respiratory support, 5 minute Apgar \<7, hypoxic-ischemic encephalopathy, seizure, infection (confirmed sepsis or pneumonia), meconium aspiration syndrome, birth trauma (bone fracture, neurologic injury or retinal hemorrhage), cephalohematoma, intracranial or subgaleal hemorrhage, or hypotension requiring vasopressor support, breastfeeding rates, hypoglycemia requiring intravenous treatment, jaundice requiring treatment, need for transfusion.
Time frame: Pregnancy to 6 week postpartum
Length of hospital stay
Length of hospital stay (in minutes) for both mom and baby
Time frame: Start of induction to delivery; admission to delivery; and delivery until discharge, assessed up until 6-weeks postpartum
Hospital readmission rates
The proportion of mothers and/or infants re-admitted to the hospital
Time frame: Delivery to 6-weeks postpartum
Techniques for induction of labour
What method was used for induction
Time frame: Admission to hospital until delivery, assessed up to 7 days from hospital admission.
Maternal satisfaction
Maternal satisfaction with study design and procedures, measured by a survey
Time frame: Approximately 48-hours post-birth and 42+/-7 days postpartum
Healthcare provider satisfaction
Healthcare provider satisfaction with study design and procedures, measured through a survey
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.